Bull Hedging
  • Politics
  • Stocks
  • Business
  • Investing
  • Politics
  • Stocks
  • Business
  • Investing

Bull Hedging

Politics

Bipartisan senators’ bill would require Congress to approve new tariffs

by admin April 4, 2025
April 4, 2025
Bipartisan senators’ bill would require Congress to approve new tariffs

Two senior lawmakers have introduced a bipartisan bill that would reassert Congress’ powers over U.S. tariffs, a day after President Donald Trump announced a new wide-ranging tariff strategy during his ‘Liberation Day’ speech on Wednesday.

Sens. Chuck Grassley, R-Iowa, and Maria Cantwell, D-Wash., on Thursday introduced the Trade Review Act of 2025, which would require the president to notify Congress about any new tariffs within 48 hours of imposition. 

The bill also requires that Trump provide an explanation of the rationale along with an analysis of the tariffs’ potential impact on the U.S. economy. Congress would have to approve the new tariffs within 60 days or allow them to expire.

If enacted, the bill would shift certain trade policymaking powers from the executive branch to the Congress. 

‘For too long, Congress has delegated its clear authority to regulate interstate and foreign commerce to the executive branch,’ Grassley, a Trump ally who is skeptical of tariffs, said in a statement. 

‘Building on my previous efforts as Finance Committee Chairman, I’m joining Senator Cantwell to introduce the bipartisan Trade Review Act of 2025 to reassert Congress’ constitutional role and ensure Congress has a voice in trade policy,’ he continued.

Cantwell said in a statement that Trump’s tariffs would hurt sectors such as agriculture, manufacturing and technology and have reverberating effects on consumers.

‘Ultimately, consumers will pay the price,’ Cantwell said in a statement. ‘It’s time for Congress to take action to counter the president’s trade war.’

Grassley’s home state of Iowa heavily relies on farm crop exports, while Cantwell’s Washington state is home to many export-heavy companies such as Boeing.

Trump on Thursday compared the tariffs to a medical operation, and said the ‘patient lived, and is healing.’ ‘The prognosis is that the patient will be far stronger, bigger, better, and more resilient than ever before,’ he wrote on Truth Social.

Thursday’s bill was introduced after four Republican senators joined Democrats in approving a separate resolution on Wednesday that would repeal Trump’s emergency declaration levying tariffs on Canadian imports. Grassley was not one of the Republican defectors. The resolution is likely dead on arrival in the House.

This post appeared first on FOX NEWS

previous post
Trump urged to review UN immunity, lax visa rules amid national security concerns
next post
Waltz’s Signal chat woes snowball as Trump admin defends national security advisor

Related Posts

DAVID MARCUS: Drone debacle perfect end to Biden’s...

December 16, 2024

Sen Cotton warns Iran to seek peace, lists...

June 23, 2025

House Democrats call on Rubio to allow injured...

August 27, 2025

Charlie Kirk honored by 90K in one of...

September 22, 2025

Trump warns Honduras of ‘hell to pay’ if...

December 2, 2025

Less than half of DOGE-terminated contracts can be...

May 30, 2025

Trump touts ‘most successful’ first 100 days in...

April 30, 2025

Trump reveals who he believes left infamous bag...

March 2, 2025

First bipartisan shutdown negotiations surface on Capitol Hill...

October 2, 2025

HHS employees offered $25k as ‘incentive to voluntarily...

March 10, 2025

Recent Posts

  • The Real Drivers of This Market: AI, Semis & Robotics
  • S&P 500 Breaking Out Again: What This Means for Your Portfolio
  • Republican populism craters as Trump stumbles, Democrats surge
  • Trump admin warned to take front seat as UN chief race shifts left, boosting anti-US contenders
  • GOP unveils plan for ‘Trump Health Freedom Accounts’ to replace Obamacare subsidies with state waivers

Recent Comments

No comments to show.

About Us

About Us

Design Magazine

Welcome to Design Magazine. Follow us for daily & updated design tips, guide and knowledge.

Stay Connect

Facebook Twitter Instagram Pinterest Youtube Email

Recent Posts

  • The Real Drivers of This Market: AI, Semis & Robotics

    December 6, 2025
  • S&P 500 Breaking Out Again: What This Means for Your Portfolio

    December 6, 2025
  • Republican populism craters as Trump stumbles, Democrats surge

    December 6, 2025
  • Trump admin warned to take front seat as UN chief race shifts left, boosting anti-US contenders

    December 6, 2025
  • GOP unveils plan for ‘Trump Health Freedom Accounts’ to replace Obamacare subsidies with state waivers

    December 6, 2025
  • Abortion restrictions create major roadblock for bipartisan Obamacare subsidy deal in Senate

    December 6, 2025

Editors’ Picks

  • 1

    Small Caps are Set to Skyrocket in 2025—Here’s What You Need to Know

    December 12, 2024
  • 2

    Environmental Approval for Boland Infield Studies & Update on Scaled Column ISR Test

    September 19, 2025
  • 3

    Ad revenue should stabilize for media companies in 2025 — if they have sports

    December 31, 2024
  • 4

    Trump leaves China guessing what his next move is with unusual inauguration invitation

    December 15, 2024
  • 5

    Zinc Stocks: 4 Biggest Canadian Companies in 2025

    January 15, 2025
  • 6

    Lead Price Forecast: Top Trends for Lead in 2025

    January 11, 2025
  • 7

    Uranium Price Forecast: Top Trends That Will Affect Uranium in 2025

    December 19, 2024
Promotion Image

banner

Categories

  • Business (602)
  • Investing (2,582)
  • Politics (3,117)
  • Stocks (946)
  • About us
  • Contacts
  • Privacy Policy
  • Terms and Conditions
  • Email Whitelisting

Disclaimer: bullhedging.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


Copyright © 2025 bullhedging.com | All Rights Reserved